Kenna Nettles, PA
Physician Assistant · Mobile, ALNPI 1992076467
Payments from drug & device makers
Across 78 payments — averaging $20.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$221
- Takeda Pharmaceuticals U.S.A., Inc.$150
- AstraZeneca$136
- Incyte Corporation$126
- Novartis$124
- Pfizer$106
- plus $750 from 22 others
What the payments were for
- Food & beverage$1,612100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 11 | $221 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $150 |
| AstraZeneca(2 entities) | 7 | $136 |
| Incyte Corporation | 6 | $126 |
| Novartis | 6 | $124 |
| Pfizer | 2 | $106 |
| Johnson & Johnson | 5 | $95 |
| Merck | 5 | $89 |
| Novo Nordisk | 3 | $66 |
| Astellas Pharma US Inc | 3 | $61 |
| Sanofi | 2 | $42 |
| Stemline Therapeutics Inc. | 2 | $42 |
| Pharmaessentia USA Corporation | 1 | $34 |
| Morphosys, US Inc. | 2 | $34 |
| AVEO Pharmaceuticals, Inc. | 2 | $32 |
| Tolmar, Inc. | 2 | $31 |
| Daiichi Sankyo Inc. | 1 | $29 |
| Bayer | 1 | $27 |
| Genentech USA, Inc. | 1 | $21 |
| EMD Serono, Inc. | 1 | $18 |
| Alnylam Pharmaceuticals Inc. | 1 | $18 |
| Coherus Oncology, Inc. | 1 | $18 |
| Karyopharm Therapeutics Inc. | 1 | $17 |
| Pharmacosmos Therapeutics Inc. | 1 | $17 |
| Recordati_rare_diseases_inc. | 1 | $16 |
| Genmab U.S., Inc. | 1 | $15 |
| G1 Therapeutics, Inc. | 1 | $15 |
| Seagen Inc. | 1 | $15 |
How this compares
$1,612 in reported general payments places this provider in the 70th percentile of 846 physician assistant providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Abiraterone Acetate | 16 | $18,365 |
| Tamsulosin Hcl | 57 | $968 |
| Allopurinol | 21 | $118 |
| Amlodipine Besylate | 12 | $90 |
| Prednisone | 14 | $50 |
| Ondansetron Hcl | 12 | $39 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in Mobile
- Ashley PeaceMobile$27K
- Gregory SharpMobile$19K
- Elizabeth SimpsonMobile$18K
- Jessica DavisMobile$15K
- Alyssa HollingsworthMobile$14K
- Jessica KantralesMobile$14K
- Mary HneichMobile$12K
- James GunnMobile$10K
- Taryn ThompsonMobile$10K
- Hannah SmithMobile$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.